共催セミナー(録画等)

Current management of endometriosis-related infertility and pain.
-Debate and Commentary-

- Endometriosis surgery for infertility is not as good as one would think
(Luk Rombauts, WES President)

Luk Rombauts

  • Head of Reproductive Medicine, Monash Medical Centre, Melbourne, Australia
  • Adjunct Clinical Professor in the Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia
  • President, Fertility Society of Australia and New Zealand

Luk Rombauts became president of the World Endometriosis Society in May 2021.

After the completion of his PhD at the Catholic University of Leuven (Belgium) in 1994, Professor Rombauts completed a 2-year International Fellowship at Monash University in Melbourne. He was then appointed as a staff specialist at the Leuven Institute of Fertility and Embryology (Belgium). He returned to Melbourne in 1998 to join Monash IVF. He obtained his subspecialty Certificate of Reproductive Endocrinology and Infertility (CREI) in 2001 and is now accredited by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as a training supervisor for the CREI.

Professor Rombauts is the Group Medical Director of Monash IVF and previously served on the Monash IVF Board of Company Directors. He is a Research Fellow of the Hudson Institute. He has published over 150 papers in peer-reviewed journals and his main research interests include endometriosis and embryo implantation.

Professor Rombauts was elected a board member of the World Endometriosis Research Foundation in 2008. He is the President of the Fertility Society of Australia and New Zealand. He was the scientific programme chair of the 10th World Congress of Endometriosis in 2008 and of the 14th World Congress on Human Reproduction in 2011.
Professor Rombauts was elected a board member of the World Endometriosis Society in 2008, and served as its president elect between 2017-2021.

- Endometriosis surgery for infertility is maybe better than one would think
(Neil Johnson, Former WES President)

Neil Johnson

  • Gynaecologist and Fertility Sub-specialist, Repromed, Auckland, New Zealand
  • Adjunct Professor, University of Adelaide, Australia
  • Honorary Clinical Academic, University of Auckland, New Zealand

Neil Johnson’s (MD CREI FRCOG FRANZCOG MRCGP) main research interests are in evidence based gynaecology and fertility treatments, the fertility aspects of endometriosis (for which he has pioneered the use of lipiodol in New Zealand and internationally), and polycystic ovary syndrome.

Neil previously served on, and latterly chaired, the board of Endometriosis New Zealand from 2004 – 2019, and chaired the Royal Australian & New Zealand College of Obstetricians & Gynaecologists (RANZCOG) Reproductive Endocrinology & Infertility (REI) Subspecialty Training Committee from 2009 – 2012. He was inaugural chair of the ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence) Group from its inception in 2008 to 2014 and the multicentre clinical trials network REACT-ANZ (Reproduction And Clinical Trials – Australia and New Zealand) from 2006 to 2014. He had the privilege of convening the Montpellier WES consensus on the management of endometriosis in 2011, the Sao Paulo WES consensus on diagnosis and classification of endometriosis in 2014, and the San Antonio WES consensus on specialist care and networks of expertise in endometriosis in 2017. He is the New Zealand representative to the Asia Pacific Initiative on Reproduction (ASPIRE).
Neil Johnson was appointed to the board of the World Endometriosis Society in March 2008 and, having served as its Vice President from 2011-2014, was appointed President Elect in April 2014, and was President from May 2017 through May 2021.

- Management of endometriosis-related infertility: Commentary on Japanese Guideline and our experiences
(Kaori Koga, Chiba University)

Kaori Koga

  • Professor in the Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan

Kaori Koga, M.D., Ph.D. is a physician-scientist and a Professor of the Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. Kaori received her M.D. degree from Chiba University in 1996, Chiba, Japan, and her Ph.D. degree from the University of Tokyo in 2003. She then undertook post-doctoral fellowships in the Uterine Biology Group (Prof. Lois Salamonsen’s laboratory) at Prince Henry’s Institute, Melbourne, Australia in 2006, and the Reproductive Immunology Unit (Prof. Gil Mor’s laboratory) at the Department of Obstetrics, Gynecology and Reproductive Sciences in Yale University in 2006–2008. Kaori specializes in the management of endometriosis, including minimally invasive surgery (MIS) such as laparoscopic and robotic-assisted surgery, and assisted reproductive technology. Dr. Koga is author or co-author of more than 200 scientific articles published in peer-reviewed international journals, such as and Nature Reviews Disease Primers. Professor Koga is an ambassador of the World Endometriosis Society and a member of the European Society of Human Reproduction and Embryology, American Society for Reproductive Immunology, International Society for Immunology of Reproduction.

- Optimal pharmacotherapy for endometriosis based on the clinical practice guidelines in Japan
(Fuminori Taniguchi, Tottori University)

Fuminori Taniguchi

  • Professor in the Department of Obstetrics & Gynecology, Tottori University Faculty of Medicine, Yonago, Japan
  • Chief of secretary-generals in Japan Endometriosis Society (JES) since 2020.

His main research works have been the basic investigation with regard to the pathogenesis of endometriosis and the treatment for endometriosis-associated infertility and pain. After the completion of his PhD at the Tottori University in 1998, he worked as the Instructor of Ob& Gyn, Tottori University Faculty pf Medicine. From 2004 to 2006, he studied in NIEHS/NIH (National institute Environmental health and Sciences), Research Triangle Park, North Carolina, USA, Dr. Kenneth Korach Lab.) as a Research Fellow. Then, he returned to Tottori University, and obtained his subspecialty certificate of Japan Society for Reproductive Medicine (JSRM), and that of Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE; Laparoscopy and Hysteroscopy). He became the ambassador of Asian Society of Endometriosis and Adenomyosis (ASEA) in 2019 and was elected as the Professor of the Ob & Gyn, Tottori University in 2021.